Ondansetron vs Prochlorperazine for Nausea and Vomiting in the Emergency Department
Completed · Phase 2
Conditions studied: Nausea and Vomiting
In brief
This study will compare the effect of prochlorperazine and ondansetron for the treatment of nausea and vomiting in the emergency department.
Key facts
- Study ID
- NCT00590317
- Run by
- Emory University
- People needed
- 64
- Starts
- 2005-03-01
- Expected to finish
- 2008-09-01
- Last updated by the study team
- 2014-05-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Patients presenting to the ED with at least one of the following
- Nausea
- Vomiting documented in the ED
You may not qualify if…
- Previous treatment in the ED with Ondansetron, prochlorperazine, promethazine or metaclopramide
- Patients with missed last menstrual period
- Pregnancy
- Age < 18 years old
- Treatment with antineoplastic agents within 7 days prior to randomization
- Irritable bowel syndrome
- Gastroparesis
- Suspected gastrointestinal bleed
- Suspected intestinal obstruction
- Preexisting motor disorder (Restless-leg syndrome or Parkinson's disease)
- Traumatic brain injury upon admission to ED
- Intracranial hemorrhage upon admission to ED
- Patients unable to read, write or communicate in the English language
- Patients leaving the ED against medical advice
Where it is running
- Grady Hospital — Atlanta, Georgia, United States
- Grady Memorial Hospital — Atlanta, Georgia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.